Jamie Clark
Stock Analyst at Rothschild & Co
(2.17)
# 2,610
Out of 4,989 analysts
9
Total ratings
57.14%
Success rate
7.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Buy | $311 | $259.94 | +19.64% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $342 → $474 | $497.32 | -4.69% | 1 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $184 → $236 | $167.49 | +40.90% | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $149.45 | +21.78% | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $279.35 | -1.20% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $186.82 | +4.38% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $181.24 | +52.28% | 1 | Oct 14, 2024 |
West Pharmaceutical Services
Sep 15, 2025
Initiates: Buy
Price Target: $311
Current: $259.94
Upside: +19.64%
Medpace Holdings
Sep 3, 2025
Downgrades: Neutral
Price Target: $342 → $474
Current: $497.32
Upside: -4.69%
ICON Public Limited Company
Sep 3, 2025
Upgrades: Buy
Price Target: $184 → $236
Current: $167.49
Upside: +40.90%
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $149.45
Upside: +21.78%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $279.35
Upside: -1.20%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $186.82
Upside: +4.38%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $181.24
Upside: +52.28%